Comments
Sun Pharmaceutical Industries on Monday said it has launched ophthalmic solution Cequa used for the treatment of dry-eye disease in the US market. One of the company’s wholly owned subsidiaries has commercialised Cequa 0.09 per cent in the US, Sun Pharma said.
The product offers the highest concentration of cyclosporine for ophthalmic use approved by the United States Food and Drug Administration. Cequa is indicated to increase tear production in patients with dry eye.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.